Vitals
- Oral semaglutide approved — first GLP-1 pill for weight loss hits market; injection barrier removed
- Telemedicine → $180B by 2031 — 13% compound annual growth rate, virtual care now structural
- Home healthcare → $954B by 2033 — 7.8% growth, decentralized care accelerating
- Hospital-at-home extended through 2030 — Congress passed five-year extension
- Medicaid work requirements enacted — states must implement by January 2027
Peaks
The GLP-1 Pill Changes Everything
The FDA approved oral semaglutide (Wegovy) as the first GLP-1 pill for weight loss. No injections. No specialty pharmacy. A daily tablet. Novo Nordisk launched the 25mg oral formulation in early January 2026.
Why it matters: The GLP-1 access bottleneck was always supply and injection hesitancy. Oral formulations remove the second barrier. Watch employer coverage decisions in Q2-Q3 as the math changes.
Virtual Psychiatry Scales Into the Gap
Talkiatry closed a $210 million Series D led by Perceptive Advisors, bringing total funding to over $400 million. The virtual psychiatry platform is targeting a market where 150 million Americans live in mental health professional shortage areas.
Why it matters: Behavioral health access has been broken for decades. Virtual models are finally proving they can scale. This isn't telehealth as stopgap; it's telehealth as primary delivery system.
Home Healthcare Becomes the Default
The home healthcare market is projected to grow from $580 billion to $954 billion by 2033 at 7.8% compound annual growth rate. Congress extended hospital-at-home waivers through September 2030 via the Hospital Inpatient Services Modernization Act.
Why it matters: The regulatory scaffolding is in place. The capital is flowing. Home isn't an alternative site of care anymore. For chronic disease management, it's becoming the primary one.
Troughs
MA Exits Create Access Deserts
UnitedHealth is exiting 109 counties in 16 states, affecting 180,000 Medicare Advantage enrollees. Aetna is closing nearly 90 MA plans across 34 states, reducing its footprint by 100 counties. The exits cluster in rural and underserved markets where risk adjustment doesn't cover actual utilization.
Why it matters: When MA plans exit, seniors don't just switch insurers. They often lose access to provider networks, care coordination, and supplemental benefits. The exits concentrate in counties where risk adjustment doesn't cover actual utilization, leaving seniors with fewer plan options.
Medicaid Work Requirements Enacted
The One Big Beautiful Bill Act requires Medicaid-eligible adults ages 19-64 to verify at least 80 hours monthly of work, volunteering, or educational programs to maintain coverage. States must implement by January 2027, with extensions possible through December 2028.
Why it matters: The administrative burden alone will cause coverage losses before anyone fails a work test. Seven states already have active waiver applications to implement early.
AI Prior Auth Enters Traditional Medicare
CMS launched the WISeR (Wasteful and Inappropriate Service Reduction) Model, deploying AI and machine learning to screen prior authorization for select services in traditional Medicare. The model covers three service categories: skin and tissue substitutes, electrical nerve stimulator implants, and knee arthroscopy for knee osteoarthritis.
Why it matters: Traditional Medicare was the last holdout from aggressive utilization management. WISeR is the first Innovation Center model using technology companies as the only participants. If it works, expect expansion. Access increasingly flows through algorithms.
Trends
Telehealth Permanence Is No Longer a Question
The telemedicine market is projected to grow from $85.5 billion in 2025 to $180 billion by 2031 at 13% CAGR. Congress extended Medicare telehealth flexibilities. Virtual care is approaching 30% of all U.S. medical visits.
Why it matters: The regulatory fights are over. The debate now is how to integrate virtual into hybrid models, not whether it survives.
State Hospital Pricing Caps Spreading
Thirteen states considered hospital pricing legislation in 2025. Indiana enacted HB 1004 requiring nonprofit hospitals to offer direct contracting to employers at no more than 260% of Medicare rates, effective September 2025. Washington and Vermont also enacted pricing reforms.
Why it matters: Federal antitrust action is slow. States are moving first. Pricing caps directly affect who can afford care. Access follows affordability.
Pharmacy Becomes the Front Door
Health systems are repositioning pharmacy as strategic infrastructure. Site-of-care optimization is being cited as the "strongest lever" for cost reduction. Specialty pharmacy integration and 340B optimization are driving margin recovery strategies.
Why it matters: Pharmacy isn't a cost center anymore. It's an access point, a margin driver, and increasingly, the most convenient touchpoint for chronic disease management.
So What?
Access is being rebuilt from the ground up.
The old model assumed: hospital as hub, insurance as gatekeeper, physician as bottleneck. Each of those is shifting.
Care is decentralizing. Home healthcare grows at 8% annually. Telehealth hits 30% of visits. Oral GLP-1s remove the injection barrier. Hospital-at-home extends through 2030. The physical plant matters less than the care model.
Coverage is fragmenting. MA exits concentrate in underserved markets. Medicaid work requirements threaten millions. The people who most need access are watching their options narrow.
Technology is intermediating. AI prior auth enters traditional Medicare. Virtual psychiatry scales into shortage areas. Algorithms increasingly decide who gets what care, when.
The winners will be organizations that understand access as infrastructure, not service. Build the pathways. Meet people where they are. The care site is wherever the patient is.
For professionals: Oral GLP-1s change your prescribing calculus. Review your patient panels for candidates who refused injections. Prepare for Medicaid churn as work requirements phase in.
For leaders: Map your MA exposure by county. If UnitedHealth or Aetna is exiting your market, your payer mix is about to shift. Build hybrid care delivery now.
For builders: Home health, virtual behavioral health, and pharmacy-as-access-point are the growth vectors. The regulatory runway is clear through 2030.
On the Calendar
- Feb 27 — Washington, DC Mixer
- Mar 5 — Houston Mixer
- Mar 6 — Atlanta Mixer
- Mar 20 — Baltimore Mixer
- Mar 26 — Detroit Mixer
- Mar 27 — NYC Mixer